GLP-1s

Diabetes Obesity Opthalmology Pharmaceuticals

Growing concerns over semaglutide, tirzepatide eye stroke link

Diabetes Pharmaceuticals Weight management

Obesity drug leads to 25% weight loss in a third of patients

Diabetes Obesity Pharmaceuticals

Why microdosing GLP-1s is not OK

Clinical Diabetes

GLP-1 GP restrictions ‘ludicrous, short-sighted’